We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$2.3B
AUM Growth
+$74.7M
Cap. Flow
+$189M
Cap. Flow %
8.22%
Top 10 Hldgs %
31.66%
Holding
197
New
49
Increased
45
Reduced
38
Closed
57

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.72%
2 Healthcare 20.5%
3 Technology 14.65%
4 Consumer Discretionary 9.4%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$95.7M 4.16%
800,000
-1,030,000
-56% -$118M
VC icon
2
Visteon
VC
$2.72B
$95.5M 4.15%
+893,989
New +$86.3M
TSN icon
3
Tyson Foods
TSN
$19.5B
$82.6M 3.59%
2,061,500
+1,386,500
+205% +$56.2M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$78.3M 3.4%
6,074,616
+3,927,012
+183% +$49.2M
IBB icon
5
PUT
iShares Biotechnology ETF
IBB
$10.5B
$75.8M 3.3%
+750,000
New +$72.9M
MU icon
6
Micron Technology
MU
$1.05T
$64.9M 2.82%
1,853,300
+907,300
+96% +$30M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$61.7M 2.68%
300,000
-685,000
-70% -$138M
AAPL icon
8
Apple
AAPL
$4.67T
$60.2M 2.62%
+2,180,400
New +$59.3M
CDK
9
DELISTED
CDK Global, Inc.
CDK
$57M 2.48%
+1,397,700
New +$49.5M
CBRE icon
10
CBRE Group
CBRE
$43.7B
$56.7M 2.47%
1,656,782
+656,782
+66% +$21M
AGN
11
DELISTED
Allergan plc
AGN
$48.8M 2.12%
189,569
+128,100
+208% +$32M
AGN
12
DELISTED
Allergan Inc
AGN
$42.3M 1.84%
198,750
+50
+0% +$9.94K
UAL icon
13
United Airlines
UAL
$35.9B
$41.4M 1.8%
618,200
+383,200
+163% +$21.2M
C icon
14
CALL
Citigroup
C
$223B
$40.6M 1.76%
750,000
-400,000
-35% -$21.2M
PANW icon
15
Palo Alto Networks
PANW
$303B
$38.3M 1.66%
1,873,800
-136,200
-7% -$2.51M
VNDA icon
16
Vanda Pharmaceuticals
VNDA
$320M
$35.2M 1.53%
2,461,305
+656,125
+36% +$7.76M
CDW icon
17
CDW
CDW
$18.5B
$33.9M 1.47%
+964,400
New +$31.2M
SUNE
18
DELISTED
SUNEDISON, INC COM
SUNE
$33.6M 1.46%
1,724,400
+574,400
+50% +$10.9M
QQQ icon
19
PUT
Invesco QQQ Trust
QQQ
$489B
$33M 1.44%
+320,000
New +$32.4M
ANAC
20
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$32.9M 1.43%
1,019,275
+91,521
+10% +$2.75M
QLIK
21
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$29.9M 1.3%
967,500
+117,500
+14% +$3.35M
TIME
22
DELISTED
Time Inc.
TIME
$29.5M 1.28%
+344,800
New +$7.8M
TERP
23
DELISTED
TerraForm Power, Inc
TERP
$28.3M 1.23%
917,600
+597,600
+187% +$17M
XBI icon
24
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$28M 1.22%
+450,000
New +$25.7M
KRE icon
25
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
$26.5M 1.15%
650,000
-100,000
-13% -$3.92M

Similar funds

Kingdon Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Kingdon Capital Management held 197 positions worth $2.3B, up 3.4% from $2.23B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Kingdon Capital Management deployed $189M of net new capital in Q4 2014, opening 49 new positions and adding to 45 existing holdings. Its largest new stake was Visteon: 893,989 shares worth $95.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was HCA Healthcare, an estimated $99.3M trimmed.

  • Kingdon Capital Management's largest Q4 2014 buy was Visteon: 893,989 shares worth $95.5M.
  • Kingdon Capital Management added most to Tyson Foods in Q4 2014, an estimated $56.2M increase.
  • Kingdon Capital Management's biggest Q4 2014 reduction was HCA Healthcare, cutting an estimated $99.3M.
  • Kingdon Capital Management fully exited Weatherford International plc in Q4 2014, selling an estimated $54.3M.
  • Kingdon Capital Management's ten largest holdings make up 32% of its $2.3B portfolio in Q4 2014.
  • Kingdon Capital Management opened 49 new positions and closed 57 in Q4 2014.
  • Kingdon Capital Management's portfolio value rose 3.4% quarter-over-quarter to $2.3B.

Based on Kingdon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.